[1] Brown JA,Dorfrman DM,Ma FR,et al.Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.J lmmunol,2003,170 (3):1257-1266. [2] Strome SE,Dong H,Tamura H,et al.B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma.Cancer Res,2003,63(19):6501-6505. [3] He YF,Zhang GM,Wang XH,et al.Eukaryotic expression and functional characterization of PD-1 extracellular domain.Sheng Wu Gong Cheng Xue Bao,2004,20(5):699-703. [4] He YF,Zhang GM,Wang XH,et al.Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine.J Immunol,2004,173(8):4919-4928. [5] Maruyama H,Higuchi N,Kameda S,et al.Rat liver-targeted naked plasmid DNA transfer by tail vein injection.Mol Biotechnol,2004,26(2):165-172. [6] Mourich DV,Munks MW,Murphy JC,et al.Spermine compaction is an efficient and economical method of producing vaccination-grade DNA.J Immunol Methods,2003,274 (1-2):257-264. [7] 黄波,冯作化,李东,等.人T淋巴细胞白血病不同细胞株的混合抗原肽诱导特异性CTLs细胞毒效应及其交叉反应性分析中华肿瘤杂志,2003,25(1):9-12. [8] Nguyen LT,Radhakrishnan S,Ciric B,et al.Cross-linking the B7 family molecule B7-DC directly activates immune functions of dendritic cells.J Exp Med,2002,196(10):1393-1398. [9] Koga N,Suzuki J,Kosuge H,et al.Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts.Arterioscler Thromb Vasc Biol,2004,24(11):2057-2062. |